SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADGI TO ACQUIRE SEXI?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hubert Few who wrote (13)6/8/1996 6:59:00 AM
From: Hubert Few   of 70
 
TO ALL: UNITED BIOMEDICAL, DR."T", ETC.

The last 2 posts all came from the other
ADGI folder here, there is a lot of info
on the company if anyone cares to go back
to the start of the thread and go forward.

Any attempt to discredit Dr. Thornwaite's
association with ADGI, would logically
discredit his association with SEXI, and
others.

Also, it is common knowledge that ADGI has
planned acquisitions of two more companies.
All of this is available information, We
can speculate to no end, who is going to do
what, but there is SPECIFIC mention of an
alliance with a video teleconferencing
concern.

I have not researched each and every article
as to authenticity, there are REASONABLE limits
to what a person can do.

MAY 30TH PRESS RELEASE:
American Diversified Group Acquires United Biomedical Inc.

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--May 30, 1996--American
Diversified Group Inc. (NASDAQ OTC BB:ADGI) announced the finalization of their
acquisition of United Biomedical Inc., a biotech firm, headquartered in Miami,which
deals in medical products and services.

United Biomedical has source, supply, marketing and distribution agreements for a
number of products and services including human serum albumin in South and Central
American, FDA approved test kits for cholera, gonorrhea, syphilis and strep,
marketing rights in Mexico for the DNA Analyzer, the most precise instrument for the
measurement of the DNA content in cancer cells, Tumor Chemosensitivity Assays, for
determining the most effective chemotherapeutic drugs for the treatment of cancer
patients, screening and monitoring programs for the treatment of cancer patients as well
as a number of products and services in the developmental stages.

Dr. Jerry T. Thornthwaite, chairman of United Biomedical Inc., is a cancer researcher
and scientist and highly recognized in the fields of instrumentation, reagents and clinical
applications in flow cytometry, image analysis and luminometry, including
immunological, biochemical and biophysical properties of cells and their
characterization from solid tumors for receptor assays and monoclonal antibody
production against breast, colon and lung cancers. He has over 60 technical
publications and has established Oncology laboratories at Cedars Medical Center and
Baptist Hospital in Miami. United Biomedical and
Dr. Thornthwaite bring both national and international networks of contacts and
relationships in the scientific, medical and business fields to ADGI.

The acquisition is a tax-free stock exchange between ADGI and UBI and is another
significant step in ADGI's planned growth by the addition of select synergistic
companies, programs and energies to an already existing dynamic base. UBI maintains
offices and laboratory facilities at a medical facility in Miami.

CONTACT: American Diversified Group
800/793-4469
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext